Prosecution Insights
Last updated: May 29, 2026
Application No. 18/243,495

METHODS OF MAKING AN EXPANDABLE SHEATH

Non-Final OA §102
Filed
Sep 07, 2023
Priority
Jul 25, 2018 — provisional 62/702,993 +1 more
Examiner
HALL, DEANNA K
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Edwards Lifesciences Corporation
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
5m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
869 granted / 1147 resolved
+5.8% vs TC avg
Strong +15% interview lift
Without
With
+15.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
43 currently pending
Career history
1199
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
71.9%
+31.9% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
1.1%
-38.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1147 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Acknowledgments This office action is in response to the claims filed on 9/7/23 and on 3/18/24 applicant elected without traverse to prosecute the article claims, claims 13-20. Claims 1-20 are pending with claims 1-12 being withdrawn. Information Disclosure Statement The information disclosure statements (IDS) submitted on 12/15/23; 11/3/25 are in compliance with the provisions of 37 CFR 1.97(b). Accordingly, the IDSs are being considered by the Examiner. Allowable Subject Matter Claim 14 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claims 15-20 are further objected to based on dependency. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 13 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bonutti et al. (US 6,814,715) (“Bonutti”). Bonutti discloses: An expandable sheath 400 comprising: an annular member 402 (C8L60-65) including: inward extending channels Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DEANNA K HALL whose telephone number is (571)272-2819. The examiner can normally be reached M-F 8:30am- 4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DEANNA K HALL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Sep 07, 2023
Application Filed
Mar 12, 2024
Examiner Interview (Telephonic)
Mar 12, 2024
Examiner Interview Summary
Feb 09, 2026
Non-Final Rejection mailed — §102
May 11, 2026
Interview Requested

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635940
CLOSED-LOOP DRUG INFUSION SYSTEM WITH SYNERGIC CONTROL
3y 7m to grant Granted May 26, 2026
Patent 12636423
MAGNETIC CONTROL OF FLUID IN A FLUID MANAGEMENT SYSTEM
3y 5m to grant Granted May 26, 2026
Patent 12623057
SECUREMENT ASSEMBLY AND METHOD FOR CENTRAL VENOUS ACCESS DEVICES AND SURGICAL DRAINS
3y 8m to grant Granted May 12, 2026
Patent 12622868
Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug
3y 6m to grant Granted May 12, 2026
Patent 12623059
MULTI-USE BLOOD CONTROL SAFETY CATHETER ASSEMBLY
3y 4m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
91%
With Interview (+15.4%)
3y 2m (~5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1147 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month